| Study Period | 2019 - 2030 |
| 乐鱼体育官网 Size (2025) | USD 728.44 Million |
| 乐鱼体育官网 Size (2030) | USD 943.94 Million |
| CAGR (2025 - 2030) | 5.32 % |
| Fastest Growing 乐鱼体育官网 | Asia Pacific |
| Largest 乐鱼体育官网 | North America |
| 乐鱼体育官网 Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Intracardiac Echocardiography (ICE) 乐鱼体育官网 Analysis
The Intracardiac Echocardiography 乐鱼体育官网 size is estimated at USD 728.44 million in 2025, and is expected to reach USD 943.94 million by 2030, at a CAGR of 5.32% during the forecast period (2025-2030).
The COVID-19 outbreak had an unprecedented impact on the growth of the 乐鱼体育官网. This outbreak resulted in the postponement and cancellation of various cardiac surgeries, affecting the demand for products in the Intracardiac Echocardiography devices 乐鱼体育官网. The research article published by Europe PMC in July 2021 mentioned a 73% reduction in cardiac surgeries and a 74.3% reduction in catheterisation procedures from April to August 2020 in India. Such a reduction in cardiac procedures had a slight negative impact on the 乐鱼体育官网's growth. However, with the relaxation of the lockdown, these postponed surgeries were carried out. COVID-19 has also impacted the cardiac health of people, increasing the demand for Cardiac Diagnostic Imaging such as Intracardiac Echocardiography. Hence, the studied 乐鱼体育官网 is expected to regain its growth over the coming five years.
The significant factors for the growth of the Intracardiac Echocardiography 乐鱼体育官网 include the growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in interventional cardiology devices and Cardiac Imaging Software. Additionally, the burden of cardiac diseases is rising with the prevailing sedentary lifestyle of the population, which boosts the 乐鱼体育官网's growth. According to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people lived with heart or circulatory disease in 2021. Such increasing prevalence of cardiovascular diseases led to the need for early diagnosis and imaging techniques such as Intracardiac Echocardiography, thus driving the 乐鱼体育官网's growth.
Also, adopting Intracardiac Echocardiography catheters in surgical procedures is expected to contribute to the Intracardiac Echocardiography catheter 乐鱼体育官网 growth. For instance, in July 2021, the first minimally-invasive heart procedure using its real-time 3D Intracardiac Echocardiography catheter was conducted. Such adoption of Intracardiac Echocardiography procedures is expected to drive the Intracardiac Echocardiography 乐鱼体育官网 growth over the forecast period.
Factors such as the high burden of cardiovascular diseases, the rising geriatric population, and increasing usage of Intracardiac Echocardiography and other Cardiac Imaging techniques are expected to contribute to the Echocardiography 乐鱼体育官网 growth over the forecast period. However, factors such as the high cost, inadequate reimbursement, and lack of awareness in developing and underdeveloped countries are expected to restrain the 乐鱼体育官网's growth over the forecast period.
Intracardiac Echocardiography (ICE) 乐鱼体育官网 Trends
Electrophysiology is Expected to Hold a Significant Share in the 乐鱼体育官网 Over the Forecast Period
Electrophysiology (EP) is a test performed to assess the heart's electrical system or activity and is used to diagnose abnormal heartbeats or arrhythmia. EP is performed by inserting catheters and wire electrodes, which measure electrical activity through blood vessels that enter the heart, often using Intracardiac Echocardiography catheters.
In electrophysiology procedures, Intracardiac Echocardiography (ICE), also known as Intracardiac Echo, allows the integration of real-time images with electroanatomic maps, which has a role in assessing arrhythmogenic substrate. It is particularly useful for mapping structures that are not visualised by fluoroscopies, utilizing a Cardiac Mapping System. Therefore, ICE is preferred over other diagnostic methods. With the increasing prevalence of arrhythmia in populations worldwide, the demand for electrophysiology procedures is expected to increase over the years, and the studied segment is expected to grow significantly.
According to the BMJ article published in August 2021, around 80% of the study participants diagnosed with atrial fibrillation in the United Kingdom were eligible for early rhythm control. Such prevalence of atrial fibrillation in the population eligible for early rhythm control is expected to drive the demand for electrophysiology procedures, thus contributing to the growth of the Intracardiac Echocardiography 乐鱼体育官网.
With technological innovations, along with the rising adoption of imaging procedures for electrophysiology, the segment is further expected to grow over the forecast period. For instance, in July 2021, Mayo Clinic used a next-generation 4D ICE catheter in patients to guide heart procedures. The technology can also help physicians perform procedures without using general anesthesia on patients.
The increasing prevalence of various heart and circulatory disorders among the global population, and the rising demand for electrophysiology procedures are expected to contribute to the growth of the studied segment during the forecast period.
Understand The Key Trends Shaping This 乐鱼体育官网
Download PDF
North America is Expected to Hold a Significant Share in the 乐鱼体育官网 and Expected to do Same Over the Forecast Period
With the rising focus on patient care and need, supported by the well-developed infrastructure and technologically advanced healthcare system, the increasing burden of cardiac diseases is expected to drive the growth of the Intracardiac Echocardiography 乐鱼体育官网 in the region.
Additionally, the rising geriatric population is also expected to drive the growth of the 乐鱼体育官网 in this region. For instance, the data published by Statistics Canada in August 2022 indicated that the population aged 70 to 74 years in Canada was 1,879,862, whereas the population aged 80 to 84 years was 878,672. Such a rise in the geriatric population who are prone to developing cardiovascular diseases is expected to drive the demand for minimally invasive cardiac procedures such as Intracardiac Echocardiography and Cardiac Imaging Systems, thereby contributing to the growth of the 乐鱼体育官网 in this region.
Furthermore, the rising product approvals and technologically advanced products are expected to boost the growth of the 乐鱼体育官网 during the forecast period. For instance, in April 2022, Franklin Mountain Medical received the Food and Drug Administration's clearance of its patented UltraNav Transseptal Catheter system for controlled access and delivery of cardiovascular catheters and guidewires to heart chambers. This visualization allows the delivery of catheters, including Intracardiac Echocardiography catheters for the intended treatment in the Intracardiac Echocardiography catheter 乐鱼体育官网.
Similarly, in January 2021, Siemens Medical Solutions USA, Inc., received approval from the United States Food and Drug Administration for the ACUSON AcuNav volumetric intracardiac echocardiography catheter for legal 乐鱼体育官网ing and usage, bolstering the Intracardiac Echocardiography devices 乐鱼体育官网.
Thus, owing to the above-mentioned factors such as innovative product launches and high burden of cardiac disease is contributing to the growth of the Intracardiac Echocardiography 乐鱼体育官网 in the North America region over the forecast period.
Get Analysis on Important Geographic 乐鱼体育官网s
Download PDF
Intracardiac Echocardiography (ICE) Industry Overview
The 乐鱼体育官网 is moderately competitive due to the presence of major 乐鱼体育官网 players at local and international levels. The major players in the Intracardiac Echocardiography devices 乐鱼体育官网 are Biomerics, Boston Scientific Corporation, Conavi Medical, Infraredx Inc., Koninklijke Philips NV, Siemens Healthcare GmbH, and Stryker Corporation, which hold a substantial 乐鱼体育官网 share.
Intracardiac Echocardiography (ICE) 乐鱼体育官网 Leaders
-
Boston Scientific Corporation
-
Stryker Corporation
-
Conavi Medical
-
Koninklijke Philips N.V
-
Siemens Healthcare GmbH
- *Disclaimer: Major Players sorted in no particular order
Need More Details on 乐鱼体育官网 Players and Competiters?
Download PDF
Intracardiac Echocardiography (ICE) 乐鱼体育官网 News
- September 2022: Baptist Health's Miami Cardiac and Vascular Institute used the VeriSight Pro, a real-time 3D intracardiac echocardiography catheter from Philips. The technology offers superior 2D and 3D live imaging guidance for a wide range of cardiac procedures in structural heart disease,
- March 2022: Seimens Healthineers launched the next-generation AcuNav Volume four-dimensional (4D) intracardiac echocardiography (ICE) catheter in the United States.
Intracardiac Echocardiography (ICE) Industry Segmentation
As per the report's scope, intracardiac echocardiography (ICE) refers to a unique imaging modality capable of providing high-resolution real-time visualization of cardiac structures, incessant monitoring of catheter location within the heart, and early detection of procedural complications, including pericardial effusion or thrombus formation.
The Intracardiac Echocardiography 乐鱼体育官网 is segmented by application (Electrophysiology, Left Atrial Appendage Closure, Transcatheter Aortic Valve Implantation, MitraClip Implantation, and Mitral Valvuloplasty, Other Applications), end users (Hospitals, Diagnostic Centers, Other End Users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Application | Electrophysiology | ||
| Left Atrial Appendage Closure | |||
| Transcatheter Aortic Valve Implantation | |||
| MitraClip Implantation and Mitral Valvuloplasty | |||
| Other Applications | |||
| By End Users | Hospitals | ||
| Diagnostic Centers | |||
| Other End Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Intracardiac Echocardiography (ICE) 乐鱼体育官网 Research FAQs
How big is the Intracardiac Echocardiography 乐鱼体育官网?
The Intracardiac Echocardiography 乐鱼体育官网 size is expected to reach USD 728.44 million in 2025 and grow at a CAGR of 5.32% to reach USD 943.94 million by 2030.
What is the current Intracardiac Echocardiography 乐鱼体育官网 size?
In 2025, the Intracardiac Echocardiography 乐鱼体育官网 size is expected to reach USD 728.44 million.
Who are the key players in Intracardiac Echocardiography 乐鱼体育官网?
Boston Scientific Corporation, Stryker Corporation, Conavi Medical, Koninklijke Philips N.V and Siemens Healthcare GmbH are the major companies operating in the Intracardiac Echocardiography 乐鱼体育官网.
Which is the fastest growing region in Intracardiac Echocardiography 乐鱼体育官网?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Intracardiac Echocardiography 乐鱼体育官网?
In 2025, the North America accounts for the largest 乐鱼体育官网 share in Intracardiac Echocardiography 乐鱼体育官网.
What years does this Intracardiac Echocardiography 乐鱼体育官网 cover, and what was the 乐鱼体育官网 size in 2024?
In 2024, the Intracardiac Echocardiography 乐鱼体育官网 size was estimated at USD 689.69 million. The report covers the Intracardiac Echocardiography 乐鱼体育官网 historical 乐鱼体育官网 size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Intracardiac Echocardiography 乐鱼体育官网 size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Intracardiac Echocardiography Industry Report
The Global Intracardiac Echocardiography 乐鱼体育官网 is segmented by application, end users, and geography. The 乐鱼体育官网 report offers an in-depth industry analysis, providing valuable industry information and an industry overview. The report highlights key industry trends and industry statistics, which are essential for understanding the 乐鱼体育官网 dynamics.
The 乐鱼体育官网 segmentation includes applications such as Electrophysiology, Left Atrial Appendage Closure, Transcatheter Aortic Valve Implantation, MitraClip Implantation, and Mitral Valvuloplasty, among others. End users are categorized into Hospitals, Diagnostic Centers, and other end users. The geographic segmentation covers North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
The 乐鱼体育官网 forecast outlines the expected 乐鱼体育官网 growth and industry outlook. The industry research includes a 乐鱼体育官网 review and 乐鱼体育官网 predictions, focusing on the 乐鱼体育官网 size and 乐鱼体育官网 value. The report provides insights into the 乐鱼体育官网 leaders and their strategies, contributing to the overall 乐鱼体育官网 growth.
The report example and report PDF are available for download, offering a comprehensive 乐鱼体育官网 analysis and 乐鱼体育官网 data. The 乐鱼体育官网 report is a valuable resource for research companies and industry stakeholders, providing a detailed 乐鱼体育官网 outlook and industry sales information. The report also includes a historical overview and a 乐鱼体育官网 forecast outlook, ensuring a thorough understanding of the 乐鱼体育官网 trends and 乐鱼体育官网 segmentation.
